Alexar Therapeutics was created in January 2014 by NeXeption is a biopharmaceutical management company. The company is focused on developing an innovative portfolio of Liver X receptor (LXR) agonists for both systemic and local use.

LXR agonists are members of the nuclear receptor superfamily that regulate multiple genetic pathways and exhibit potent anti-inflammatory activity.